A Turkish biotechnology company has successfully developed artificial veins that will be used in cardiovascular and neurovascular patients after additional testing.
INVAMED-RD Global announced in A declaration on Tuesday that he had produced artificial veins in laboratories using interdisciplinary research and advanced health technologies developed by expert engineers and scientists.
The prosthetic veins have almost the same level of flexibility like normal veins in a human body thanks to biotechnological infrastructures and specific 3D bio-printers, he specifies.
They will be used in treat cardiovascular and neurovascular patients because the production of artificial veins thanks to nanotechnology biopolymers allows patients to live without using drugs that help prevent blood clots.
Artificial veins were created using high-temperature teflon technologybiopolymers and 3D bioprinters, the statement said, adding that they are a significant advance in medical technology it gives hope to patients waiting for an organ transplant, car prosthetic veins can fully attach to living tissue.
Laboratory tests have shown that these veins are compatible with organic cells in the human body and patient- specific veins can be created using 3D electrospinning, 3D printers and laser scanning machines.
Raşit Dinç, the head company said that the laboratory studies were successful and the artificial veins would be used on humans if animal testing and clinical studies are successful.